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1.1. A library to optimise novel hepatitis C virus inhibitors
The hepatitis C virus is the agent responsible for hepatitis C, and
is a major factor in the development of liver cancer and chronic
liver disease. Despite the development of novel antiviral agents,
HCV infection remains a considerable public health burden, as it
is a leading cause of liver transplantations and results in around
10,000 deaths in the US each year. No vaccine against HCV infec-
tion exists. A recent paper describes the use of a high throughput
screen (HTS) to ﬁnd novel anti-HCV hit compounds, and a library
to further investigate the structure-activity relationship (SAR) [1].
A high throughput screening assay platform has been developed
that covers the entire HCV replication cycle. This assay platform
comprises a recombinant infectious virus and a stable host cell
line, and was used to interrogate the NIH Molecular Libraries
Small Molecule Repository (MLSMR) collection of over 330,000
compounds. A number of hits were identiﬁed including a series
of benzofuran derivatives exempliﬁed by compound 1. These
compounds were low micromolar inhibitors in the HCV-Luc assay
(recombinant HCV carrying a luciferase reporter) and had no
measurable cytotoxicity against Huh7.5.1 cells.
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Taking these compounds as a starting point, a number of 2,3,
5-trisubstituted benzofurans were selected from the University of
Kansas Chemical Methodologies and Library Development Center
(KU CMLD) compound collection, and screened in the HCV-Luc
assay. In addition to validating the activity of the hits from the
HTS, a number of active compounds were discovered including
ﬁve analogues that were superior in activity (EC50 6 980 nM) to
the initial hits. All ﬁve of these contained a propargyl alcohol
functionality in the C3 position, indicating that this might be an
important structural feature.
Based on these results, a library of 45 2,3,5-trisubstituted
benzofuran compounds was designed to systematically explore
SAR in this series. Suzuki-Miayura couplings of 2 gave diversehttp://dx.doi.org/10.1016/j.comche.2015.11.001
E-mail: nterrett@ensemblediscovery.comfunctionalised phenyl acetylenes (3). Cyclisation with iodine
monochloride gave intermediate 4, and a ﬁnal Sonogashira
coupling provided the ﬁnal benzofurans (5). Final compounds were
prepared in the Bohdan MiniBlock platform, and puriﬁed by
reverse phase preparative HPLC.
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Screening these library compounds in the HCV-Luc assay
revealed that the activity of individual compounds is highly
dependent on the substituents at all positions of the benzofuran
system. Compounds 6 and 7 were the most potent identiﬁed with
EC50 values of 98 and 180 nM respectively. They were also
essentially inactive in the cytotoxicity assay.
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Further investigation into the mechanism of the antiviral
activity suggested that the benzofurans were interacting with a
target in early stage HCV infection, possibly viral entry or trafﬁcking.
Further characterisation of these compounds is ongoing.
2. A summary of the papers in this month’s issue
2.1. Polymer supported synthesis
A facile, efﬁcient, racemisation-free, and environmentally
friendly protocol for the synthesis of peptide hydroxamic acids
directly from carboxylic/amino acids by ethyl 2-(tert-butoxycar-
bonyloxyimino)-2-cyanoacetate has been described. The compati-
bility of this method with Fmoc based solid phase peptide
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large N-terminal peptide hydroxamic acids on resin [2].
Solid-phase total synthesis of cyclodepsipeptide spiruchostatin
A has been achieved. Immobilisation of a Boc-d-Val-statine deriva-
tive via a hindered b-hydroxy group was efﬁciently achieved using
polymer-supported silyl triﬂate. Subsequently, the peptide chain
was successfully extended on the polymer-support to yield the
tetrapeptide cyclisation precursor in high purity. Macrolactonisa-
tion proceeded smoothly and release of the macrolactone from
the polymer-support followed by in situ disulﬁde formation pro-
vided spiruchostatin A in 17% overall yield [3].
A convenient multicomponent reaction for the synthesis of a
variety of rarely investigated 1,3-benzothiazine-2-thiones using
carbon disulﬁde, primary amines and ortho-halogenated benzalde-
hydes has been reported. The high performance of the newly
developed one-pot procedure enables a direct route to a wide
range of analogue annulated polyheterocyclic structures [4].
2.2. Solution-phase synthesis
A ligand-free copper-catalysed Goldberg coupling of a spiro-
cyclic lactam with an aryl iodide or bromide to provide an N-aryl
spirocyclic lactam in good to excellent yields has been reported.
The protocol is applicable to the synthesis of a broad range of
spirocyclic lactams. Products can be used for the preparation of
tetra- and pentacyclic compounds as potential therapeutic agents
in the treatment of diffuse large B-cell lymphoma and triple nega-
tive breast cancer [5].
The chemoselective introduction of ﬂuorinated moieties into
biologically relevant scaffolds is now an established strategy to
modulate the properties of lead molecules. For the ﬁrst time, the
diversity oriented synthesis of multivalent glycomimetics incorpo-
rating hexaﬂuorovaline through a straightforward multicompo-
nent sequential process has been described. The process, which
occurs with high yield and under mild conditions, has been suc-
cessfully applied to the chemistry of aminoglycosides producing
a neomycin-hexaﬂuorovaline-galactose conjugate and provides a
general, efﬁcient strategy to functionalised aminoglycosides with
sugar-hexaﬂuorovaline tags [6].
2.3. Scaffolds and synthons for combinatorial libraries
A novel method for decarboxylative benzoyloxylation of
b-hydroxy amino acids using photoredox catalyst Ru(bpy)3Cl26H2O
and benzoylperoxide (BzO)2 has been described. The strategy has
been expanded to the synthesis of structurally diverse chiral
1,2-amino alcohols with different aryl or alkyl groups, starting from
serine or threonine derivatives [7].
2.4. Solid-phase supported reagents
Fe3O4-OSO3H has been identiﬁed as an efﬁcient reusable solid
catalyst for the facile synthesis of diarylmethyl indole derivatives
through C–C bond forming reactions under neat conditions. The
catalysis was further extended to C–N bond forming reactions
and for the synthesis of spermicidal 3,30-di(indolyl)oxindole
derivatives, with all products being obtained in good to excellent
yields [8].
Magnetic nanoparticles (Fe3O4) coated with chicken feather
have been synthesised and subsequently grafted with palladium
nanoparticles (Pd NPs) using an in situ preparation approach. The
synthesised catalyst showed excellent activity for Suzuki cross
coupling reaction between aryl halides and phenylboronic acid.
After completion of the reaction, the catalyst could conveniently
be separated via magnetic separation, and the presence of amino
and carboxyl groups on the surface due to the chicken feather,provided sufﬁcient binding sites for Pd NPs, making the
synthesised material highly stable [9].
The effectiveness of MBHA-bound dipeptidic organocatalysts
in the asymmetric aldol reaction between cyclohexanone and
several aldehydes has been evaluated. Under optimum reaction
conditions, which involved the use of Brønsted acid and water as
additives, it was found that the presence of one glycine or one
b-alanine residue resulted in improved stereoselectivity. A repre-
sentative organocatalyst was re-used as catalyst in ﬁve consecutive
cycles in the asymmetric aldol reaction maintaining its
effectiveness, although some loss in yield and stereoselectivity
was observed [10].
2.5. Novel resins, linkers and techniques
No papers this month.
2.6. Library applications
A new library of triazole-imidazo [2,1-b][1,3,4]thiadiazole
hybrids has been designed by a molecular hybridisation approach
and the target molecules were synthesised via a one pot click
chemistry protocol. All the intermediates and ﬁnal molecules were
characterised using spectral methods. The derivatives were
screened for their antimycobacterial activity againstMycobacterium
tuberculosis H37Rv strain, and two compounds demonstrated
signiﬁcant growth inhibitory activity [11].
In order to expand the structural diversity of Bcr-Abl inhibitors,
twenty hybrids based on Imatinib and GNF-2 have been synthe-
sised and characterised. Biological activities were evaluated
in vitro against human leukemia cells, and most compounds exhib-
ited potent antiproliferative activity against K562 cells. Further-
more, these new hybrids were also screened for Abl kinase
inhibitory activity, and some of them inhibited Abl kinase with
low micromolar IC50 values [12].
A new library of 2-(30-indolyl)-N-arylthiazole-4-carboxamides
has been designed and synthesised. Antibacterial activity evalua-
tion against Gram-positive and Gram-negative bacterial strains
led to several compounds being identiﬁed as potent and selective
(Gram-negative) antibacterial agents [13].
A small library of monovalent and bivalent Smac mimics have
been synthesised based on two types of monomers, with general
structure NMeAla-Xaa-Pro-BHA (Xaa = Cys or Lys). Position 2 of
the compounds was used to dimerise both types of monomers
employing various bis-reactive linkers, as well as tomodify selected
compounds with lipids. The resulting library was screened in vitro
against metastatic human breast cancer cell line MDA-MB-231,
and the two most active compounds selected for in vivo studies.
The most active lipid-conjugated analogue showed in vivo activity
while administered both subcutaneously and orally [14].
Libraries of spiro[cyclopropane-1,30-indolin]-20-ones have been
synthesised and evaluated for their biological activity against ﬁve
different human cancer cell lines. Many compounds of the series
exhibited promising anticancer activity (IC50 < 20 lM) against the
studied cell lines, and a structure activity relationship of the phar-
macophore was proposed. Two compounds showed signiﬁcant
activity against the human prostate cancer cell line, DU-145, and
ﬂow cytometric analysis showed that these two compounds
arrested the cell cycle in the G0/G1 phase leading to caspase-3
dependent apoptotic cell death [15].
Previous studies on the natural product chlorofusin have shown
that the full peptide and azaphilone structure are required for inhi-
bition of the interaction between MDM2 and p53. In a recent pub-
lication, the cyclic peptide has been used as a template and an
azidonorvaline amino acid introduced in place of the ornithine/
azaphilone of the natural product. From this small library the ﬁrst
N.K. Terrett / Combinatorial Chemistry - An Online Journal 17 (2015) 47–50 49ever non-azaphilone containing chlorofusin analog with MDM2/
p53 activity was identiﬁed. Further studies suggested that the
simple structure of the Fmoc-norvaline amino acid that had
undergone a click reaction was also able to inhibit MDM2/p53
interaction [16].
A library of curcumin mimics with diverse alkylsulfonyl and
substituted benzenesulfonyl modiﬁcations has been prepared.
The compounds were tested for their vasodilatation effect on depo-
larisation (50 mM K+)- and endothelin-1 (ET-1)-induced basilar
artery contraction. Generally, curcumin mimics with aromatic sul-
fonyl groups showed stronger vasodilation effect than alkyl sul-
fonylated curcumin mimics. Based on their biological properties,
synthetic curcumin mimics can act as a dual antagonist scaffold
of L-type Ca2+ channel and endothelin A/B2 receptor in vascular
smooth muscle cells [17].
We have reported design, synthesis and in vitro biological eval-
uation of a library of bicyclic lactams that led to the discovery of a
novel class of a-glucosidase inhibitors. These compounds inhibited
a-glucosidase in a mixed type of inhibition with an IC50 of
150 nM. Molecular docking studies further substantiated screen-
ing results, and in addition, phenotypic screening of this library
against the human malaria parasite revealed one compound as a
potent antiplasmodial agent [18].
To verify vesamicol as lead structure in the development of
radioligands for imaging of VAChT in the brain by PET, the mole-
cule has been systematically modiﬁed by the investigation of four
different groups of derivatives. Structural changes were conducted
in all three ring systems resulting in a library of different vesamicol
analogs. Based on their in vitro binding afﬁnity toward VAChT as
well as r1 and r2 receptors, a structure-afﬁnity relationship study
was undertaken regarding both afﬁnity and selectivity. The
compounds possessed VAChT afﬁnities in the range of 1.32 nM
(benzovesamicol) to >10 lM and selectivity factors from 0.1 to
73 regarding r1 and r2 receptors, respectively. It was observed
that most of the compounds with high VAChT afﬁnity demon-
strated considerable afﬁnity in particular to the r1 receptor [19].
An efﬁcient synthetic strategy has been developed to modulate
the structure of the tetrahydropyridine isoindolone (Valmerin)
skeleton. A library of more than 30 novel ﬁnal structures was gen-
erated, and biological activities on CDK5 and GSK3 as well as cellu-
lar effects on cancer cell lines were measured for each novel
compound. In particular, a strong GSK3/CDK5 dual inhibitor was
obtained, and a set of highly selective GSK3 inhibitors was synthe-
sised by ﬁne-tuning structural modiﬁcations. Antiproliferative
effects on cells were correlated with the in vitro kinase activities
and the best effects were obtained with lung and colon cell lines
[20].
Metronidazole has been used clinically for over 50 years as an
antiparasitic and broad-spectrum antibacterial agent effective
against anaerobic bacteria. However resistance has been reported,
and improved second-generation metronidazole analogues are
needed. The copper catalysed Huigsen azide-alkyne 1,3-dipolar
cycloaddition offers a way to efﬁciently assemble new libraries of
metronidazole analogues, and several new metronidazole-triazole
conjugates have been identiﬁed with excellent broad spectrum
antimicrobial and antiparasitic activity targeting Clostridium
difﬁcile, Entamoeba histolytica and Giardia lamblia [21].
A recent study describes the discovery of a series of highly
potent hepatitis C virus (HCV) NS5A inhibitors based on symmetri-
cal prolinamide derivatives of benzidine and diaminoﬂuorene.
Through modiﬁcation of benzidine, L-proline, and diaminoﬂuorene
derivatives, novel inhibitor structures were developed, which
allowed the design of a library of potent HCV NS5A inhibitors.
Through a battery of studies including hERG ligand binding assay,
CYP450 binding assay, rat plasma stability test, human liver micro-
somal stability test, and pharmacokinetic studies, key compoundswere found to be nontoxic, and expected to be effective therapeutic
anti-HCV agents [22].
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